Literature DB >> 11274943

Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris.

S Fuchs1, R C Hendel, D S Baim, J W Moses, A Pierre, R J Laham, M K Hong, R E Kuntz, M Pietrusewicz, R O Bonow, G S Mintz, M B Leon, R Kornowski.   

Abstract

The assessment of left ventricular electromechanical activity using a novel, nonfluoroscopic 3-dimensional mapping system demonstrates considerable differences in electrical and mechanical activities within regions of myocardial infarction or ischemia. We sought to determine whether these changes correlate with indexes of myocardial perfusion, viability, or ischemia. A 12-segment comparative analysis was performed in 61 patients (45 men, 61 +/- 12 years old) with class III to IV angina, having reversible and/or fixed myocardial perfusion defects on single-photon emission computed tomographic perfusion imaging. A dual-isotope protocol was used, consisting of rest and 4-hour redistribution thallium images followed by adenosine technetium-99m sestamibi imaging. Average rest endocardial unipolar voltage (UpV) and local shortening (LS) mapping values were compared with visually derived perfusion scores. There was gradual and proportional reduction in regional UpV and LS in relation to thallium-201 uptake score at rest (p = 0.0001 and p = 0.0002, respectively) and redistribution studies (p = 0.0001 and p = 0.003, respectively). UpV > or = 7.4 mV and LS > or = 5.0% had a sensitivity of 78% and 65%, respectively, with a specificity of 68% and 67% for detecting viable myocardium. UpV values of 12.3 and 5.4 mV had 90% specificity and sensitivity, respectively, to predict viable tissue. UpV, but not LS, values differentiated between normal segments and those with adenosine-induced severe perfusion defects (11.8 +/- 5.3 vs 8.8 +/- 4.1 mV, p = 0.005). Catheter-based left ventricular assessment of electromechanical activity correlates with the degree of single-photon emission computed tomographic perfusion abnormality and can identify myocardial viability with a greater accuracy than myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274943     DOI: 10.1016/s0002-9149(00)01529-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Myocardial gene and cell delivery.

Authors:  P D Lambiase; M S Marber
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 2.  Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.

Authors:  Peter J Psaltis; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2008-12-10       Impact factor: 4.132

Review 3.  Intramyocardial navigation and mapping for stem cell delivery.

Authors:  Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-23       Impact factor: 4.132

Review 4.  The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations.

Authors:  Timm Dickfeld; Christopher Kocher
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

5.  A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease.

Authors:  Guilherme V Silva; Marlos R Fernandes; Cristiano O Cardoso; Ricardo R Sanz; Edie M Oliveira; Pilar Jimenez-Quevedo; Javier Lopez; Franca S Angeli; Yi Zheng; James T Willerson; Emerson C Perin
Journal:  Tex Heart Inst J       Date:  2011

6.  Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy.

Authors:  Peter J Psaltis; Angelo Carbone; Darryl P Leong; Dennis H Lau; Adam J Nelson; Tim Kuchel; Troy Jantzen; Jim Manavis; Kerry Williams; Prashanthan Sanders; Stan Gronthos; Andrew C W Zannettino; Stephen G Worthley
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-29       Impact factor: 2.357

Review 7.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

8.  Prognostic validation of an algorithm to convert myocardial perfusion SPECT imaging data from a 12-segment model to a 17-segment model.

Authors:  Michael Salerno; Laine Elliot; Linda K Shaw; Jonathan P Piccini; Robert Pagnanelli; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2009-06-03       Impact factor: 5.952

9.  Histopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia.

Authors:  Yi Zheng; Marlos R Fernandes; Guilherme V Silva; Cristiano O Cardoso; John Canales; Amir Gahramenpour; Fred Baimbridge; Maria da Graça Cabreira-Hansen; Emerson C Perin
Journal:  Exp Clin Cardiol       Date:  2008

10.  Comparison of NOGA endocardial mapping and cardiac magnetic resonance imaging for determining infarct size and infarct transmurality for intramyocardial injection therapy using experimental data.

Authors:  Noemi Pavo; Andras Jakab; Maximilian Y Emmert; Georg Strebinger; Petra Wolint; Matthias Zimmermann; Hendrik Jan Ankersmit; Simon P Hoerstrup; Gerald Maurer; Mariann Gyöngyösi
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.